ID   ZR-75-1 shPARG
AC   CVCL_RA95
SY   shPARG ZR-75-1
DR   cancercelllines; CVCL_RA95
DR   Wikidata; Q54996115
RX   PubMed=29166620;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; 8605; PARG.
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Omics: Poly-ADP-ribosylation by proteomics.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 9
//
RX   PubMed=29166620; DOI=10.1016/j.celrep.2017.10.106;
RA   Zhen Y.-L., Zhang Y.-J., Yu Y.-H.;
RT   "A cell-line-specific atlas of PARP-mediated protein
RT   Asp/Glu-ADP-ribosylation in breast cancer.";
RL   Cell Rep. 21:2326-2337(2017).
//